MOLECULAR MECHANISMS OF MULTI-STAGE CARCINOGENESIS
多阶段致癌的分子机制
基本信息
- 批准号:3071917
- 负责人:
- 金额:$ 6.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-09-18 至 1994-09-17
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction calcium flux carcinogenesis cellular oncology chemical carcinogenesis embryo /fetus tissue /cell culture genetic transcription immunoelectron microscopy laboratory mouse molecular oncology mutant neoplasm /cancer genetics oncogenes phorbols protein kinase C skin neoplasms tumor promoters
项目摘要
The experimental approach to understanding the molecular basis of
multistage carcinogenesis focuses on unraveling the puzzle of how cellular
regulation occurs in the presence of multiple influences. As such the
results will uniquely complement studies of components of signal
transduction paths done largely in isolation of the many other facets of
cellular regulation. The primary points of this investigation are the
signal transducing enzyme protein kinase C (PKC), also known to be the
receptor for tumor promoting phorbol esters, and proteins encoded by
oncogenes that have demonstrated roles in intracellular signal
transduction, such as src, ras, raf, mye, and jun. A molecular approach
will be used to modify the signal transducing apparatus of mouse embryo C3H
10T1/2 cells and to analyze the effects of these cellular phenotype. Since
the major subject of this investigation is signal transduction mediated by
PKC a large segment of the effort is to be put into understanding the
biochemistry of PKC function and regulation as well as to learn more about
the molecular and cellular biology of PKC. The interactions of multiple
elements of cellular signal transduction will be investigated at the same
time. One of the goals is to combine these separate data to develop a
better idea of the molecular apparatus in cells that integrates the
transduced extracellular signals to yield a single outcome. It is probable
that resistance of some cells and strains of mice to tumor promoting agents
such as phorbol esters involves alterations in the integrative apparatus
making study of such resistant cells useful. Lastly, somatic cell genetics
system will be developed for investigating the transcytoplasmic phase of
cellular signal transduction that begins with PKC and ends with activation
of gene transcription. The latter study, together with the information that
will be obtained about the interactions of signal transduction, will make
it possible to obtain a more complete understanding of the process of
cellular signal transduction and how it is involved in multistage
carcinogenesis.
理解生物化学分子基础的实验方法
多阶段致癌作用的重点是解开细胞如何
调节发生在多种影响存在的情况下。因而
结果将独特地补充信号成分的研究
转导途径主要是在隔离的许多其他方面,
细胞调节本次调查的主要内容是
信号转导酶蛋白激酶C(PKC),也被称为
促进肿瘤的佛波醇酯的受体和由其编码的蛋白质
已证实在细胞内信号传导中起作用的癌基因
转导,如src,ras,raf,mye和jun。
将用于改造小鼠胚胎C3 H的信号转导装置
10 T1/2细胞,并分析这些细胞表型的影响。以来
本研究的主要主题是由
PKC的很大一部分工作是为了了解
PKC功能和调节的生物化学以及了解更多信息
PKC的分子和细胞生物学。多重的相互作用
细胞信号转导的元素将在同一时间进行研究,
时间目标之一是将这些独立的数据联合收割机组合起来,
更好的想法是细胞中的分子装置,
转导细胞外信号以产生单一结果。很可能
一些细胞和小鼠品系对肿瘤促进剂的抗性
例如佛波醇酯涉及整合器官的改变
使得对这种抗性细胞的研究变得有用。最后,体细胞遗传学
系统将被开发用于研究转胞质相的
以PKC开始并以激活结束的细胞信号转导
基因转录。后一项研究报告,以及
将获得关于信号转导的相互作用,将使
可以更全面地了解这个过程,
细胞信号传导及其如何参与多阶段
致癌作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CURTIS L. ASHENDEL其他文献
CURTIS L. ASHENDEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CURTIS L. ASHENDEL', 18)}}的其他基金
INHIBITORS OF THE RAS-RAF-MAP KINASE SIGNALLING PATHWAY
RAS-RAF-MAP 激酶信号通路抑制剂
- 批准号:
6300370 - 财政年份:2000
- 资助金额:
$ 6.86万 - 项目类别:
INHIBITORS OF THE RAS-RAF-MAP KINASE SIGNALLING PATHWAY
RAS-RAF-MAP 激酶信号通路抑制剂
- 批准号:
6102642 - 财政年份:1999
- 资助金额:
$ 6.86万 - 项目类别:
INHIBITORS OF THE RAS-RAF-MAP KINASE SIGNALLING PATHWAY
RAS-RAF-MAP 激酶信号通路抑制剂
- 批准号:
6269454 - 财政年份:1998
- 资助金额:
$ 6.86万 - 项目类别:
INHIBITORS OF THE RAS-RAF-MAP KINASE SIGNALLING PATHWAY
RAS-RAF-MAP 激酶信号通路抑制剂
- 批准号:
6237154 - 财政年份:1997
- 资助金额:
$ 6.86万 - 项目类别:
相似海外基金
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
- 批准号:
10322143 - 财政年份:2021
- 资助金额:
$ 6.86万 - 项目类别:
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
- 批准号:
10154169 - 财政年份:2021
- 资助金额:
$ 6.86万 - 项目类别:
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
- 批准号:
10540812 - 财政年份:2021
- 资助金额:
$ 6.86万 - 项目类别:
Boron accelerates cultured osteoblastic cell activity through calcium flux
硼通过钙流加速培养的成骨细胞活性
- 批准号:
25670812 - 财政年份:2013
- 资助金额:
$ 6.86万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Claudin 12 mediates paracellular calcium flux between opossum kidney cell monolayers
Claudin 12 介导负鼠肾细胞单层之间的细胞旁钙通量
- 批准号:
240882 - 财政年份:2011
- 资助金额:
$ 6.86万 - 项目类别:
Molecules & Mechanisms Mediating Proximal Tubular Calcium Flux
分子
- 批准号:
244633 - 财政年份:2011
- 资助金额:
$ 6.86万 - 项目类别:
Salary Programs
Mercury induced disruptions of cellular calcium flux in paired neurons from lymnaea affect synaptic transmission and elicit apoptosis
汞诱导的成对神经元中细胞钙通量的破坏影响突触传递并引发细胞凋亡
- 批准号:
348881-2007 - 财政年份:2007
- 资助金额:
$ 6.86万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's














{{item.name}}会员




